‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
<iframe title="Libsyn Player" style="border: none" src="//html5-player.libsyn.com/embed/episode/id/16990616/height/90/theme/custom/thumbnail/no/direction/backward/render-playlist/no/custom-color/d4bf69/" height="90" width="100%" scrolling="no" allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen></iframe>
Beyond the Journal
Dr. Sanjay Popat, Debating With Us Where the Dust Has Settled with Adjuvant Osimertinib After the ADAURA Trial | BTJ-003
30
00:00:00
/ 00:48:31
30
